Category Archives: DTC Advertising


It is a different era of enforcement. So far the first quarter of 2017 has not yielded a single regulatory action letter from the Office of Prescription Drug Promotion (OPDP). That said, in December of 2016 OPDP put out more … Continue reading

Posted in DTC Advertising, Warning Letters | Comments Off

Health for Sale – What Would DDMAC Do?

Last week I was fortunate enough to catch a segment of the PBS News Hour that featured a new exhibit at the Philadelphia Art Museum called “Health for Sale“. ┬áThe exhibit is comprised of the direct-to-consumer (DTC) of yesteryear – … Continue reading

Posted in DTC Advertising, Miscellaney, Uncategorized | Comments Off

MAD Doctors! FDA Deputizes Docs to do DDMAC Ad Reviews!

 "Paging Dr. Draper!  Paging Dr. Draper!  We have an ad in the examination room that requires your attention, STAT!"  The PA system goes quiet.  In the waiting room, patients shuffle their feet nervously, waiting, waiting, waiting…. Dr. Draper enters the … Continue reading

Posted in DTC Advertising, FDA Policy, Warning Letters | 3 Comments

FDLI Conference – Part 2 – Janet Woodcock Speech

At the opening of the 20th Food and Drug Law Institute Conference Annual Advertising and Promotion Conference, CDER's Dr. Janet Woodcock stood in for Dr. Margaret Hamburg who was said to have had a scheduling conflict due to a meeting … Continue reading

Posted in DTC Advertising, FDA Policy | Comments Off

Should FTC Oversee Online Communications?

As is well known, FDA's DDMAC has stubbornly refused to deliver any guidance for industry and for advertisers on what is and is not acceptable in communications on the Internet.  Instead, the agency has repeatedly stated that it is not … Continue reading

Posted in DTC Advertising | Comments Off